Trade Mark Journal No.2026/026 26 June 2026
WO0000001922114 (35,42)
Office of origin: Australia
Date of International Registration:31 March 2026
Date of designation in the UK:
31 March 2026
International priority date claimed: 13 November 2025
(Australia)
(2603567)
- Class 35
- Business management, organisation and administration; strategic development, business management and implementation of business plans for the development and commercialisation of drugs and therapies; business management services relating to commercialisation of technology, processes and products; promoting public awareness in the field of cancer research; advisory, consultancy, business management and organisational services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services.
- Class 42
- Scientific services and related research services; scientific research; chemistry research; medical research; scientific and medical research and development; product development; scientific research and product development in the field of pharmaceuticals and biotechnology; research and development of pharmaceuticals for the treatment of cancer; medical research in the field of oncology; scientific research for medical purposes in the field of cancerous diseases; laboratory research and analysis; pharmaceutical research; drug development; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; assessing the safety and efficiency relating to pharmaceuticals; laboratory testing; quality control; advisory and consultancy services in relation to the foregoing; providing information, including online, in regard to all the aforesaid services.
Liro Therapeutics Pty Ltd
Representative: HWL Ebsworth Lawyers, PO Box 3,, Collins St West, Melbourne VIC 8007, AUSTRALIA